Instruction by Subject Matter Experts in Advanced Manufacturing Technologies

The contract outlines the delivery of four in-person training sessions designed to enhance the knowledge of FDA CDER staff in continuous and additive pharmaceutical manufacturing techniques alongside regulatory review principles. These sessions will be conducted by qualified subject matter experts with proven experience in advanced manufacturing technologies and applicable regulatory frameworks. The training is intended to build technical capacity within the agency to support modernization efforts in pharmaceutical production and evaluation. All sessions must take place in Silver Spring, Maryland, and are structured to ensure direct, hands-on engagement with instructors who are deeply familiar with current industry practices and FDA expectations. The opportunity is classified as a subcontract under NAICS code 611430 and was posted on July 23, 2026, with a response deadline of August 4, 2026. The contracting agency is the FDA Center for Drug Evaluation and Research, operating under the Department of Health and Human Services. While no set-aside type is specified, the solicitation is open to eligible subcontractors capable of delivering specialized, high-level instruction to federal personnel. The contract does not include a point of contact or detailed office address beyond the place of performance, and all proposals must be submitted through the designated SAM.gov portal by the stated deadline to be considered.